Obalon Therapeutics Inc, San Diego, reports it has received two new patents providing additional coverage for its proprietary intragastric balloon system and specific technological components.
These new patents — US Patent No. 10,327,936 and US Patent No. 10,335,303 — include an encapsulated gastric balloon with a push catheter assembly to aid balloon placement in patients that may not be able to easily swallow the capsule, and the company’s self-sealing valve system that is critical to enabling the use of gas to fill the balloon.
Obalon now has 22 patents issued in the US and 31 patents issued internationally covering its proprietary Obalon Balloon System and 24 and 55 patent applications pending in the US and international territories, respectively, according to the company.
“These patents add to the intellectual property portfolio covering our swallowable, gas-filled intragastric balloon system in the US,” says Mark Brister, Obalon’s chief technology officer, in a media release.
“We believe that our novel technology platform featuring the Obalon Balloon, Obalon Navigation System, and our Obalon Touch Inflation Dispenser significantly differentiates our product offering from liquid-filled intragastric balloons.”
[Source(s): Obalon Therapeutics Inc, GlobeNewswire]